Cargando…

A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes

Triple-negative breast cancer is a heterogeneous disease with different molecular and histological subtypes. The Androgen receptor is expressed in a portion of triple-negative breast cancer cases and the activation of the androgen receptor pathway is thought to be a molecular subtyping signature as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Taobo, Zhao, Guiyang, Liu, Yiqiang, Long, Mengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226237/ https://www.ncbi.nlm.nih.gov/pubmed/34159849 http://dx.doi.org/10.1177/15330338211027900

Ejemplares similares

Intraparenchymal breast leiomyoma and atypical leiomyoma
por: Long, Mengping, et al.
Publicado: (2022)

Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
por: Hu, Taobo, et al.
Publicado: (2021)

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
por: Hu, Taobo, et al.
Publicado: (2022)

A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
por: Long, Mengping, et al.
Publicado: (2021)

Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
por: Hu, Taobo, et al.
Publicado: (2021)

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
por: Wu, Jinbo, et al.
Publicado: (2022)

Tripartite genome of all species
por: Long, MengPing, et al.
Publicado: (2016)

Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019)

Androgen receptor function and targeted therapeutics across breast cancer subtypes
por: Kolyvas, Emily A., et al.
Publicado: (2022)

Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Yixi, et al.
Publicado: (2022)

Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes
por: Orrù, Sandra, et al.
Publicado: (2022)

Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023)

AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
por: Long, Mengping, et al.
Publicado: (2022)

BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
por: Huang, Jin, et al.
Publicado: (2022)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
por: Song, Qianqian, et al.
Publicado: (2022)

Expression of the Androgen Receptor and its Correlation with Molecular Subtypes in 980 Chinese Breast Cancer Patients
por: Qi, Ji-ping, et al.
Publicado: (2011)

Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis
por: Cruz-Tapias, Paola, et al.
Publicado: (2021)

Expression of androgen receptor and its regulatory molecule Lin28 in non-luminal subtype breast cancer
por: Sa-Nguanraksa, Doonyapat, et al.
Publicado: (2020)

Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy
por: Shi, Zhendong, et al.
Publicado: (2023)

The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018)

Expression of androgen receptor and prostate-specific antigen in male breast carcinoma
por: Kidwai, Noman, et al.
Publicado: (2004)

Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2013)

Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer
por: Cascianelli, Silvia, et al.
Publicado: (2020)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis
por: Zeng, Xin, et al.
Publicado: (2023)

Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer
por: Huang, Yuhong, et al.
Publicado: (2021)

Differential microRNA expression is associated with androgen receptor expression in breast cancer
por: Shi, Yaqin, et al.
Publicado: (2017)

Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer
por: Yu, Tianshi, et al.
Publicado: (2023)

Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity
por: Akella, Radha Ramadevi
Publicado: (2017)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

The importance of androgen receptors in breast cancer
por: Niţă, Irina, et al.
Publicado: (2021)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes
por: McQuerry, Jasmine A., et al.
Publicado: (2019)

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling
por: Al-Zahrani, Khalid N., et al.
Publicado: (2018)

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
por: Elahi Najafi, Mohammad Amin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k8cp10mk22ni1tjc80ugdgrmim